Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274240
Filing Date
2025-11-10
Accepted
2025-11-10 16:10:50
Documents
61
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20250930.htm   iXBRL 10-Q 2907819
2 EX-31.1 annx-ex31_1.htm EX-31.1 18031
3 EX-31.2 annx-ex31_2.htm EX-31.2 17442
4 EX-32.1 annx-ex32_1.htm EX-32.1 16122
  Complete submission text file 0001193125-25-274240.txt   9395720

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT annx-20250930.xsd EX-101.SCH 1083054
63 EXTRACTED XBRL INSTANCE DOCUMENT annx-20250930_htm.xml XML 1614841
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650) 822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 251466288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)